T. Rowe Price Associates’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
|
|||||
|
2025
Q1 | $175K | Buy |
|
|||||
|
2024
Q4 | $180K | Buy |
|
|||||
|
2024
Q3 | $237K | Hold |
|
|||||
|
2024
Q2 | $226K | Buy |
|
|||||
|
2024
Q1 | $117K | Hold |
|
|||||
|
2023
Q4 | $71K | Hold |
|
|||||
|
2023
Q3 | $75K | Buy |
|
|||||
|
2023
Q2 | $39K | Sell |
|
|||||
|
2023
Q1 | $203K | Buy |
|
|||||
|
2022
Q4 | $583K | Sell |
|
|||||
|
2022
Q3 | $838K | Sell |
|
|||||
|
2022
Q2 | $1.06M | Buy |
|
|||||
|
2022
Q1 | $560K | Buy |
|
|||||
|
2021
Q4 | $1.27M | Sell |
|
|||||
|
2021
Q3 | $2.27M | Sell |
|
|||||
|
2021
Q2 | $8.82M | Sell |
|
|||||
|
2021
Q1 | $10.6M | Sell |
|
|||||
|
2020
Q4 | $9.33M | Sell |
|
|||||
|
2020
Q3 | $18.6M | Sell |
|
|||||
|
2020
Q2 | $29.9M | Sell |
|
|||||
|
2020
Q1 | $25.1M | Buy |
|
|||||
|
2019
Q4 | $21.3M | Sell |
|
|||||
|
2019
Q3 | $26.8M | Buy |
|
|||||
|
2019
Q2 | $47.1M | Sell |
|
|||||
|
2019
Q1 | $46.9M | Sell |
|
|||||
|
2018
Q4 | $50.3M | Sell |
|
|||||
|
2018
Q3 | $108M | Sell |
|
|||||
|
2018
Q2 | $94M | Sell |
|
|||||
|
2018
Q1 | $336M | Buy |
|
|||||
|
2017
Q4 | $111M | Buy |
|
|||||
|
2017
Q3 | $28.2M | Buy |
|
|||||
|
2017
Q2 | $19.5M | Sell |
|
|||||
|
2017
Q1 | $30.2M | Buy |
|
|||||
|
2016
Q4 | $15M | Buy |
|
|||||
|
2016
Q3 | $19.9M | Buy |
|
|||||
|
2016
Q2 | $8.32M | Buy |
|
|||||
|
2016
Q1 | $6.58M | Buy |
|
|||||
|
2015
Q4 | $7.2M | Buy |
|
|||||
|
2015
Q3 | $4.14M | Buy |
|
|||||
|
2015
Q2 | $4.62M | Sell |
|
|||||
|
2015
Q1 | $4.12M | Sell |
|
|||||
|
2014
Q4 | $6.6M | Buy |
|
|||||
|
2014
Q3 | $4.14M | Buy |
|
|||||
|
2014
Q2 | $4.25M | Sell |
|
|||||
|
2014
Q1 | $16.9M | Sell |
|
|||||
|
2013
Q4 | $16.3M | Buy |
|
|||||
|
2013
Q3 | $14.9M | Sell |
|
|||||
|
2013
Q2 | $17.5M | Buy |
|